Nitrilase mutants and application thereof
US-11001823-B2 · May 11, 2021 · US
US11807883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11807883-B2 |
| Application number | US-202117240715-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 26, 2021 |
| Priority date | Nov 3, 2020 |
| Publication date | Nov 7, 2023 |
| Grant date | Nov 7, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a polypeptide tag and its application in the synthesis of pharmaceutical chemicals, the recombinant nitrilase was obtained by connecting a polypeptide tag to the N-terminus of the amino acid sequence of the nitrilase; wherein amino acids at both ends of the polypeptide tag are uncharged glycine G, and the rest are a random combination of any one or more of glycine G, histidine H, glutamic acid E, aspartic acid D, lysine K and arginine R; The activity of the recombinant nitrilase in the preparation of 1-cyanocyclohexyl acetic acid is up to 3034.7 U/g dcw, the polypeptide tag significantly improves the soluble expression of nitrilase, and the whole cell catalyst hydrolyzes 1M substrate with the same concentration 30 minutes faster than the mother enzyme. The method provided by the present invention can also be used for the biocatalytic reaction of other pharmaceutical intermediates as the substrate catalyzed by the nitrilase, improving the activity of the whole cell catalyst in reaction, and also improving the solubility of other types of nitrilases and the activity of the corresponding whole cell catalysts.
Opening claim text (preview).
The invention claimed is: 1. A recombinant nitrilase, comprising: a polypeptide tag, wherein the polypeptide tag is attached to the recombinant nitrilase on the N terminus, wherein the polypeptide tag is selected from the group consisting of: GKGKG (SEQ ID NO: 3), GKGEG (SEQ ID NO: 4), GKGHG (SEQ ID NO: 5), GRGRG (SEQ ID NO: 6), GRGGG (SEQ ID NO: 7), GHGHG (SEQ ID NO: 8), GKGKGKG (SEQ ID NO: 26), and GKGKGKGKG (SEQ ID NO: 27), wherein the polypeptide tag is universal and enhances soluble expression of the recombinant nitrilase, wherein the recombinant nitrilase has the amino acid sequence set forth in SEQ ID NO: 1, and wherein enzyme activity of the recombinant nitrilase with the polypeptide tag is at least 101.6% of the original strain. 2. The recombinant nitrilase of claim 1 , wherein the polypeptide tag is connected to the recombinant nitrilase by a linker peptide, and wherein the linker peptide is selected from the group consisting of: GKGKG-GS (SEQ ID NO: 31), GKGKG-GGS (SEQ ID NO: 32), GKGKG-GGGS (SEQ ID NO: 33), and GKGKG-GGGGS (SEQ ID NO: 34). 3. The recombinant nitrilase of claim 1 , wherein the polypeptide tag is linked to a linker peptide, and the linker peptide is selected from the group consisting of: GS, GGS, GGGS (SEQ ID NO: 29), and GGGGS (SEQ ID NO: 30).
Related publications grouped by family.
Answers are generated from the same data shown on this page.